QUALITY RISK MANAGEMENT

regarding the quality of drug substances and drug (medicinal) products across the product lifecycle. It is not intended to create any new expectations beyond the current regulatory requirements. It is neither always appropriate nor always necessary to use a formal risk management process (using recognized tools and/ or internal procedures e.g., ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download